The efficacy of a five-drug antiemetic combination during chemotherapy regimens containing cisplatin or cyclophosphamide-doxorubicin
- 30 April 1993
- journal article
- clinical trial
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 8 (3) , 126-131
- https://doi.org/10.1016/0885-3924(93)90140-q
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Influence of dexamethasone dose on the control of chemotherapy-induced nausea and vomitingEuropean Journal of Cancer and Clinical Oncology, 1991
- Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone.Journal of Clinical Oncology, 1991
- Ondansetron for the prevention of emesis induced by high-dose cisplatin. A multi-center dose-response studyCancer, 1990
- Randomized crossover comparison of high-dose intravenous metoclopramide versus a five-drug antiemetic regimenJournal of Pain and Symptom Management, 1990
- The antiemetic efficacy of secobarbital and chlorpromazine compared to metoclopramide, diphenhydramine, and dexamethasone: A randomized trialCancer, 1986
- An effective five-drug antiemetic combination for prevention of chemotherapy-related nausea and vomitingCancer Chemotherapy and Pharmacology, 1986
- Combination antiemetic therapy in cisplatin-induced nausea and vomitingCancer, 1985
- Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patientsCancer, 1985
- Neuronal 5-HT receptors in the peripheryNeuropharmacology, 1984
- ANTIEMETICS: NEUROTRANSMITTER RECEPTOR BINDING PREDICTS THERAPEUTIC ACTIONSThe Lancet, 1982